These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 55531)

  • 21. Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis.
    Del Prato S; Riva F; Devidé A; Nosadini R; Fedele D; Tiengo A
    Acta Diabetol Lat; 1980; 17(2):111-8. PubMed ID: 7004039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capacity to secrete islet hormones after subtotal pancreatectomy for pancreatic cancer.
    Ahrén B; Andrén-Sandberg A
    Eur J Surg; 1993 Apr; 159(4):223-7. PubMed ID: 8102543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects.
    Sgambato S; Passariello N; Giugliano D; Torella R; D'Onofrio F
    Acta Diabetol Lat; 1981; 18(3):235-41. PubMed ID: 7029989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.
    Vigili de Kreutzenberg S; Maifreni L; Lisato G; Riccio A; Trevisan R; Tiengo A; Del Prato S
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1023-9. PubMed ID: 2180971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of hyperglucagonaemia on blood glucose concentrations and on insulin requirements during fasting in insulin dependent diabetes mellitus.
    Clarke WL; Melton TW; Bright GM
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):557-60. PubMed ID: 6342325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.
    Wahren J
    Lancet; 1976 Dec; 2(7997):1213-6. PubMed ID: 63040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Diabetes without glucagon.
    Lancet; 1976 Apr; 1(7964):855-6. PubMed ID: 56667
    [No Abstract]   [Full Text] [Related]  

  • 31. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon and carbohydrate disorder in a totally pancreatectomized man (a study with the aid of an artificial endocrine pancreas).
    Santeusanio F; Massi-Benedetti M; Angeletti G; Calabrese G; Bueti A; Brunetti P
    J Endocrinol Invest; 1981; 4(1):93-6. PubMed ID: 7016969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.
    Muller WA; Berger M; Suter P; Cüppers HJ; Reiter J; Wyss T; Berchtold P; Schmidt FH; Assal JP; Renold AE
    J Clin Invest; 1979 May; 63(5):820-7. PubMed ID: 447830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon response to arginine after treatment of diabetes mellitus.
    Ohneda A; Ishii S; Horigome K; Yamagata S
    Diabetes; 1975 Sep; 24(9):811-9. PubMed ID: 1158041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
    Ferrero E; Casale G; Tassi G; Ciaponi A
    Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon and diabetes.
    Raskin P; Unger RH
    Med Clin North Am; 1978 Jul; 62(4):713-22. PubMed ID: 355737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of extrapancreatic glucagon to glycemic changes under chronic insulin deficiency in dogs.
    Kobayashi T; Nihei J; Ohneda A
    Tohoku J Exp Med; 1983 Dec; 141(4):481-8. PubMed ID: 6367144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is glucagon important in stable insulin-dependent diabetics?
    Barnes AJ; Bloom A; Crowley MF; Tuttlebee JW; Bloom SR; Alberti KG; Smythe P; Turnell D
    Lancet; 1975 Oct; 2(7938):734-7. PubMed ID: 52770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.